2001

Sep 17, 2001
Guidant Announces Market Release of its Most Advanced Pacemaker Systems in Japan

Several New Features Designed to Enhance Patient Management Indianapolis, IN and Tokyo, Japan - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and...

Sep 17, 2001
Guidant Expresses Support for the President and our Leaders

Patients Continue to Receive Medical Device Products on an Expedited Basis Indianapolis, Ind. - Ronald W. Dollens, president and CEO of Guidant Corporation (NYSE and PCX: GDT), expressing support...

Sep 11, 2001
Guidant Cancels Briefing at the Transcatheter Cardiovascular Therapeutics Conference

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT) announced today that it has cancelled its briefing at the Transcatheter Cardiovascular Therapeutics (TCT) conference in Washington,...

Sep 7, 2001
Guidant to Host Briefing at the Transcatheter Cardiovascular Therapeutics Conference

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the medical technology industry, will host a briefing at the Transcatheter Cardiovascular Therapeutics (TCT)...

Aug 23, 2001
Guidant Introduces Next Generation Radiotherapy System Outside of the United States

Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT) announced today that it has received European CE Mark approval of its next generation radiotherapy system. This...

Aug 22, 2001
Nicky Spaulding Promoted to Guidant Management Committee as President, Cardiac Surgery

Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT) announced today that Nicky Spaulding has been promoted to the Guidant Management Committee as president of the...

Aug 20, 2001
Guidant Elaborates on its Distribution Agreement with COOK

Agreement Intended to Accelerate Time to Market and Complements Guidant's Drug-Coated Stent Program. Guidant Announces Live Webcast of its Drug-Coated Stent Briefing Indianapolis, Ind. - Guidant...

Aug 17, 2001
Guidant Receives Approval for Full Market Release of ANCURE System

Less-Invasive Therapy Available to Treat Patients with Abdominal Aortic Aneurysms Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...

Aug 17, 2001
Guidant Appoints Debra F. Minott as Vice President, General Counsel and Secretary

Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT) today announced that Debra F. Minott, currently deputy general counsel and secretary, Guidant, has been promoted to vice president,...

Aug 15, 2001
First Patients Treated with Guidant's Next Generation Coronary Stent

Latest Stent Constructed of New Material Designed to Enhance Performance Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...

Aug 10, 2001
Appellate Court Decision Affirms the Strength of Guidant's Coronary Stent Patents

Indianapolis, Ind. - Guidant Corporation today stated that a recent U.S. Court of Appeals ruling on a coronary stent patent infringement suit affirms the strength of specific Guidant coronary...

Jul 24, 2001
Guidant Announces Worldwide Launch of New Self-Expanding Stent System

New Product Introduction Broadens Guidant's Global Line of Non-Coronary Therapies Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT) today announced the global...

Jul 18, 2001
Guidant Introduces its New Generation of Heart Failure Therapy

European Market Release of CONTAK RENEWAL, First Human Use Worldwide of CONTAK RENEWAL 2 Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT) today announced European market...

Jul 17, 2001
Guidant Reports Second Quarter Sales of $656 Million

Earnings per share reach $0.38. Double-digit sales growth projected for the third and fourth quarters. Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in technology for...

Jul 17, 2001
Physicians Resume Implants with Guidant's ANCURE System

Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, announced today that it has received an...

Jul 13, 2001
Guidant Revises Schedule for Second Quarter Earnings Release and Conference Call

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT) today announced that it has revised the schedule for the company's second quarter earnings press release and conference call from...

Jul 13, 2001
Guidant Corporation Meets With the FDA on CONTAK CD/EASYTRAK System

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT) and the U.S. Food and Drug Administration today met to identify next steps following the recent FDA Circulatory Systems Devices...

Jul 10, 2001
FDA Advisory Committee Elects Not To Recommend Guidant's CONTAK CD for Approval

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), today reported that the Circulatory Systems Device Panel of the U.S. Food and Drug Administration (FDA) elected not to recommend...

Jul 9, 2001
Guidant Receives FDA Approval of First Stent Designed Exclusively for Small Vessels in Patients Presenting with Abrupt and Threatened Abrupt Closure

Stent's Performance in Europe Supports Growth in Guidant's Stent Market Position Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT) today announced that it has...

Jun 19, 2001
Guidant Receives FDA Clearance for New Biliary Stent System

New Product Offering Further Expands Guidant's Stent Product Line Indianapolis, Ind. and Menlo Park, Calif - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...

Jun 5, 2001
Guidant Receives European Approval to Treat Long Coronary Blockages with Radiotherapy

Approval Will Allow Physicians to Treat a Greater Number of Patients Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...

Jun 4, 2001
Guidant Corporation to Donate $1 Million in Medical Technology to the Larry King Cardiac Foundation

Donation to help low-income individuals receive life-saving cardiac therapies LOS ANGELES, CA - During the Larry King Cardiac Foundation fundraiser, "An Evening with Larry King and Friends,"...

May 24, 2001
First Patients Treated With Guidant's Drug-Eluting Stent

Clinical Trial Will Be Basis for CE Mark Approval of MULTI-LINK TETRA-D(tm) Stent Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...

May 23, 2001
Guidant Announces CE Mark Approval and First European Implant of Next-Generation Heart Failure Technology

New Device Includes Diagnostic Capabilities for Better Patient Management Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT) today announced European CE Mark approval of...

May 22, 2001
Guidant Unveils Latest Coronary Stent Technology in Europe

Company Launches MULTI-LINK PENTA Stent Indianapolis, Ind. and Santa Clara, Calif. - Physicians in Europe are getting a glimpse at the latest coronary stent technology, following the European...

Show 5102550100 per page
Top